Newron Pharmaceuticals SpA (NWRN) — Cash Flow Reinvestment Rate
Newron Pharmaceuticals SpA (NWRN) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting CHF31.00K (capex CHF31.00K ) from operating cash flow of CHF33.35 Million. Check NWRN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Newron Pharmaceuticals SpA Cash Flow Reinvestment Rate (2012–2025)
Historical reinvestment intensity for Newron Pharmaceuticals SpA across 2 annual periods. Explore how much of Newron Pharmaceuticals SpA's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Newron Pharmaceuticals SpA (2012–2025)
Year-by-year capital reinvestment analysis for Newron Pharmaceuticals SpA. For live market cap and broader valuation context, see Newron Pharmaceuticals SpA market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CHF13.66 Million | CHF32.56 Million | CHF47.30K | ▲ +22121.3% |
| 2012 | 0.00x | CHF11.00K | CHF5.83 Million | CHF11.00K | — |